Skip to content

Asarina Pharma AB announces new date for the release of Annual Report for 2023

Asarina Pharma AB (publ) (”the Company”) announces today that the Board has decided to postpone the release of the Annual Report for 2023 to 28 May 2024.

The previously communicated release date was 23 May 2024. The reason for the postponement is that the final phase of the preparation of the Annual Report is taking longer than expected.

For additional information, please contact:

Jakob Dynnes Hansen, CFO, Asarina Pharma AB
Telefon: +45 5132 3698

The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).